Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Porton Pharma Solutions financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥18.7

2024-10-29

Market Capitalization

¥9.9 B

2024-10-29

Revenue

¥3.4 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue1.2B1.5B2.1B3.1B6.9B3.6B3.0B3.4B
Cost of goods sold788.4M964.3M1.2B1.8B3.4B2.2B2.3B2.4B
Gross profit379.5M573.8M857.8M1.3B3.6B1.4B717.4M991.5M
Gross profit margin, %37.5%41.6%41.5%51.7%40.1%24.2%29.5%
Operating expense total130.9M247.7M333.9M468.2M935.1M833.8M621.3M454.1M
Depreciation and amortization124.8M117.3M127.6M184.3M360.5M331.1M356.8M366.7M
EBITDA248.6M325.4M523.9M802.1M2.6B593.3M82.5M523.2M
EBITDA margin, %21.3%25.4%26.2%37.8%16.4%2.8%15.5%
EBIT121.8M192.7M396.0M559.4M2.2B268.2M(330.9M)152.6M
EBIT margin, %12.6%19.2%18.3%32.2%7.4%-11.2%4.5%
Interest income24.4M33.4M22.4M14.3M22.8M57.9M24.1M9.1M
Interest expense62.8M42.8M24.4M21.7M27.7M44.2M62.1M50.5M
Pre tax profit132.9M193.4M363.7M548.8M2.2B246.6M(374.0M)82.7M
Income tax expense21.4M13.8M40.6M73.2M309.4M71.0M(8.1M)52.3M
Net Income111.4M179.6M323.2M475.6M1.9B175.5M(366.0M)30.4M

Footer menu